Product Code: ETC4537990 | Publication Date: Jul 2023 | Updated Date: Aug 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 85 | No. of Figures: 45 | No. of Tables: 25 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market - Industry Life Cycle |
3.4 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market - Porter's Five Forces |
3.5 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market Revenues & Volume Share, By Concentration, 2021 & 2031F |
4 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the benefits of human milk oligosaccharides (HMOs) in infant nutrition. |
4.2.2 Growing demand for natural and organic ingredients in baby food products. |
4.2.3 Rising prevalence of health issues in infants, driving the need for specialized nutrition solutions. |
4.3 Market Restraints |
4.3.1 High production costs associated with extracting and purifying HMOs. |
4.3.2 Regulatory challenges and stringent approval processes for HMO-based products. |
4.3.3 Limited availability of scientific data supporting the long-term benefits of HMOs in infant health. |
5 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market Trends |
6 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market, By Types |
6.1 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By 2?? Fl, 2021 - 2031F |
6.1.4 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By 3?? Fl, 2021 - 2031F |
6.1.5 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By 3?? Sl, 2021 - 2031F |
6.1.6 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By 6?? Sl, 2021 - 2031F |
6.2 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Infant Formula, 2021 - 2031F |
6.2.3 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Functional Food & Beverages, 2021 - 2031F |
6.2.4 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Food Supplement, 2021 - 2031F |
6.3 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market, By Concentration |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Neutral, 2021 - 2031F |
6.3.3 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market Revenues & Volume, By Acidic, 2021 - 2031F |
7 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market Export to Major Countries |
7.2 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market Imports from Major Countries |
8 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market Key Performance Indicators |
8.1 Research and Development Investment in HMO innovations. |
8.2 Number of clinical trials and studies validating the efficacy of HMOs. |
8.3 Adoption rate of HMO-based products among healthcare professionals specializing in infant nutrition. |
8.4 Consumer awareness and perception of the benefits of HMOs in infant health. |
9 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market - Opportunity Assessment |
9.1 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market Opportunity Assessment, By Concentration, 2021 & 2031F |
10 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market - Competitive Landscape |
10.1 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Human Milk Oligosaccharides (HMO) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |